Update shared on 29 Nov 2025
Fair value Increased 0.61%Analysts have modestly increased their price target for Capital. The fair value has been raised from $1.74 to $1.75 per share, citing higher projected revenue growth that outweighs a slight decline in profit margin expectations.
What's in the News
- A Special/Extraordinary Shareholders Meeting is scheduled for December 11, 2025 at the London office of Panmure Liberum, Ropemaker Place. (Key Developments)
- A follow-on equity offering has been completed for £30.58 million, with ordinary shares issued at £1.07 per share in two tranches totaling over 28 million shares. (Key Developments)
- Another follow-on equity offering has been filed for £31 million, with ordinary shares also priced at £1.07 in two tranches. (Key Developments)
- The group has raised its revenue guidance for 2025 to a range of $335 million to $350 million, up from the previous estimate of $300 million to $320 million. (Key Developments)
Valuation Changes
- Fair Value per Share has risen slightly from $1.74 to $1.75.
- Discount Rate has increased modestly from 9.60% to 9.68%.
- Revenue Growth expectations have improved from 11.25% to 12.30%.
- Net Profit Margin forecast has declined from 8.74% to 7.31%.
- Future P/E ratio has increased from 14.56x to 17.17x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
